# A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

> **NCT06745297** · PHASE1 · RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 142 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3776528
- **DRUG:** Placebo matching BI 3776528
- **DRUG:** short-acting benzodiazepine

## Key facts

- **NCT ID:** NCT06745297
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-23
- **Primary completion:** 2026-08-25
- **Final completion:** 2026-08-25
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06745297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06745297, "A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06745297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*